Literature DB >> 20224

Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.

R A Hickie, W J Thompson, S J Strada, B Couture-Murillo, H P Morris, G A Robison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20224

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Novel protein inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase from glioblastoma multiforme.

Authors:  S Lal; R V Raju; R K Sharma
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

2.  Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment.

Authors:  G A Turner; R D Ellis; D Guthrie; A L Latner; J M Monaghan; W M Ross; A W Skillen; R G Wilson
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

3.  Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics.

Authors:  A P Kyriazis; A A Kyriazis; D G Scarpelli; J Fogh; M S Rao; R Lepera
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

4.  Effect of prostaglandins and hormones on cyclic AMP formation in rat hepatomas and liver tissue.

Authors:  G O Brønstad; T Christoffersen; E J Johansen; I Oye
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

5.  Patterns of cyclic nucleotides in normal and leukaemic human leucocytes.

Authors:  M Peracchi; A T Maiolo; L Lombardi; F B Catena; E E Polli
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.